SEC FORM 3/A

SEC FORM 3/ASEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Gillard John

(Last)

(First)

(Middle)

TRINITY BIOTECH PLC

IDA BUSINESS PARK, WICKLOW

(Street)

BRAY

A98 H5C8

(City)

(State)

(Zip)

IRELAND

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
TRINITY BIOTECH PLC [ TRIB ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)
04/03/2026

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
ADS	10,000	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
ADS OPTIONS	10/23/2021	10/23/2027	ADS OPTIONS	7,500	$13.45	D
ADS OPTIONS	10/23/2022	10/23/2027	ADS OPTIONS	7,500	$13.45	D
ADS OPTIONS	01/01/2023	12/19/2029	ADS OPTIONS	40,000	$5.7	D
ADS OPTIONS	04/01/2023	12/19/2029	ADS OPTIONS	40,000	$5.7	D
ADS OPTIONS	07/01/2023	12/19/2029	ADS OPTIONS	40,000	$5.7	D
ADS OPTIONS	10/01/2023	12/19/2029	ADS OPTIONS	40,000	$5.7	D
ADS OPTIONS	10/23/2023	10/23/2027	ADS OPTIONS	7,500	$13.45	D
ADS OPTIONS	01/01/2024	12/19/2029	ADS OPTIONS	40,000	$5.7	D
ADS OPTIONS	01/01/2024	12/11/2030	ADS OPTIONS	43,750	$2.4	D
ADS OPTIONS	01/01/2024	12/19/2030	ADS OPTIONS	29,167	$2.4	D
ADS OPTIONS	03/25/2024	03/25/2029	ADS OPTIONS	35,000	$5.45	D
ADS OPTIONS	04/01/2024	12/11/2030	ADS OPTIONS	43,750	$2.4	D
ADS OPTIONS	04/01/2024	12/19/2030	ADS OPTIONS	29,167	$2.4	D
ADS OPTIONS	07/01/2024	12/11/2030	ADS OPTIONS	43,750	$2.4	D
ADS OPTIONS	07/01/2024	12/19/2030	ADS OPTIONS	29,167	$2.4	D
ADS OPTIONS	10/01/2024	12/11/2030	ADS OPTIONS	43,750	$2.4	D
ADS OPTIONS	10/01/2024	12/19/2030	ADS OPTIONS	29,167	$2.4	D
ADS OPTIONS	10/23/2024	10/23/2027	ADS OPTIONS	7,500	$13.45	D
ADS OPTIONS	01/01/2025	12/11/2030	ADS OPTIONS	43,750	$2.4	D
ADS OPTIONS	01/01/2025	12/19/2030	ADS OPTIONS	29,167	$2.4	D
ADS OPTIONS	03/25/2025	03/25/2029	ADS OPTIONS	35,000	$5.45	D
ADS OPTIONS	04/01/2025	12/11/2030	ADS OPTIONS	43,750	$2.4	D
ADS OPTIONS	04/01/2025	12/19/2030	ADS OPTIONS	29,167	$2.4	D
ADS OPTIONS	07/01/2025	12/11/2030	ADS OPTIONS	43,750	$2.4	D
ADS OPTIONS	07/01/2025	12/19/2030	ADS OPTIONS	29,167	$2.4	D
ADS OPTIONS	10/01/2025	12/11/2030	ADS OPTIONS	43,750	$2.4	D
ADS OPTIONS	10/01/2025	12/19/2030	ADS OPTIONS	29,167	$2.4	D
ADS OPTIONS	01/01/2026	12/19/2030	ADS OPTIONS	29,167	$2.4	D
ADS OPTIONS	04/01/2026	12/19/2030	ADS OPTIONS	29,167	$2.4	D
ADS OPTIONS	07/01/2026	12/19/2030	ADS OPTIONS	29,167	$2.4	D⁽¹⁾

Explanation of Responses:

1. See Exhibit 99.1 for additional holdings details.

Remarks:

This Amendment to Form 3 is being filed to include one additional holding that was inadvertently omitted from the original filing due to the 30-line limit of the electronic form. This additional holding is set forth in Exhibit 99.1, which is attached hereto and incorporated herein by reference.

	/s/ John Gillard	04/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Amendment: SEC Form 3 filed by new insider Gillard John